Brendan is an epidemiologist based within the Burnet Institute’s Centre for Population Health in Melbourne, Australia. He is a public health specialist and continues to augment his knowledge and skills in the area of licit and illicit drug trends, justice health issues and infectious diseases in Australia and internationally via work on multidisciplinary research projects. Specifically, following two years with Turning Point Alcohol & Drug Centre’s Epidemiology department (2006-2008), in 2010 he established Melbourne’s first community-recruited prospective cohort of methamphetamine users for his primary PhD project (completed with Monash University’s Department of Epidemiology and Preventive Medicine). This study investigated the epidemiology of methamphetamine use in Melbourne and barriers and enablers to treatment utilisation among methamphetamine users. In 2015, Brendan was the primary supervisor of a Monash University Honours student who followed-up his PhD cohort of methamphetamine users. This makes it the longest prospective study of methamphetamine use conducted in Australia. Consequently, Dr Quinn is an emerging Australian authority on methamphetamine-related issues and continues to research and provide expert commentary on this area.

In recent years Brendan’s involvement in various projects, including consultancies for the World Health Organization, United Nations Office on Drugs and Crime, Save the Children and United Nations Children’s Fund, has facilitated the expansion of his professional interests to areas such as HIV, viral hepatitis and gender-based violence. For example, in early 2015, Brendan assisted in designing baseline research to evaluate an intervention for increasing HIV testing and treatment uptake among marginalized, at-risk youth in Bandung, Indonesia, including men who have sex with men, people who inject drugs, female sex workers and transgender individuals. He continues to collaborate on diverse projects with Australian and international researchers.

The incidence of methamphetamine-related harms affecting Australian individuals, families and communities continues to rise. In consideration of this, Brendan will travel to the United States to learn from, and work alongside, Dr Stephen Shoptaw, a world-renowned researcher of methamphetamine and other substance use issues. Dr Shoptaw’s team at the Center for Behavioral & Addiction Medicine at the University of California, Los Angeles, is conducting innovative research on methamphetamine, including novel prevention and treatment responses, unlike any current studies in Australia. The experience will augment Brendan’s knowledge, skills and experience of researching drug and alcohol issues and countering related harms, to inform necessary translational studies and evidence-based policy and preventative measures for defining and appropriately addressing the significant issue of methamphetamine use in Australia.

Home Institution Monash University, Burnet Institute
Host Institution University of California, Los Angeles
Award Name Fulbright Postdoctoral Scholarship
Discipline Public Health (Epidemiology)
Award Year 2016